Rating Change
Piper Sandler reiterated its Overweight rating on BridgeBio Oncology Therapeutics Inc. (NASDAQ:BBOT) on November 11, 2026.
Piper Sandler reiterated its Overweight rating on BridgeBio Oncology Therapeutics Inc. (NASDAQ:BBOT) on November 11, 2026.

At publication ·
BridgeBio Oncology Therapeutics Inc. (NASDAQ:BBOT) · reiterate
At a glance
Piper Sandler reiterated its Overweight rating on BridgeBio Oncology Therapeutics Inc. (NASDAQ:BBOT) on November 11, 2026.
BridgeBio Oncology Therapeutics Inc. operates in the Healthcare sector. The stock currently trades at $2.56 with a market capitalization of $1.0B. The stock has declined 81.9% over the past 52 weeks.
Analyst coverage from Piper Sandler provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for BridgeBio Oncology Therapeutics Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 11, 2026 | Wedbush | Outperform | N/A |
| Nov 11, 2026 | Piper Sandler | Overweight | N/A |
| Oct 21, 2026 | Morgan Stanley | Overweight | N/A |
| Oct 20, 2026 | Oppenheimer | Outperform | N/A |
| Sep 11, 2026 | JP Morgan | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View BBOT Stock Page
A rating of Overweight from Piper Sandler reflects the analyst's outlook on BridgeBio Oncology Therapeutics Inc. (NASDAQ:BBOT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the BBOT forecast page.
Current market data
NASDAQ · BBOT
$2.14
Down: -$0.16 · -7.48%
Live quote updated
Keep reading
analyst ·
earnings ·
price ·
analyst ·